Consumer Health Neurology
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...
July 02, 2021 | News
Watching someone you love lose their precious memories, independence, and sense of self as Alzheimer’s disease (AD) claims their mind is heartbreakin...
June 22, 2021 | Opinion | By Leidamarie Tirado-Lee
KT Corporation and NeuroSigma, Inc. jointly announced signing of a memorandum of understanding, forming a strategic partnership to develop and commercializ...
June 15, 2021 | News
Additionally, the FDA appropriately took into account the vast unmet need of the Alzheimer's community. Aduhelm is certainly not a cure, but at long last i...
June 14, 2021 | News
Brain tumors originate from the brain itself, or it can be secondary extension from other parts. Brain tumors in India comes to 5-10 in 100,000 popul...
June 08, 2021 | Opinion
Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...
June 08, 2021 | Analysis
Neurimmune welcomes the news that the U.S. Food and Drug Administration (FDA) has approved Biogen's regulatory application for the use of aducanumab in the...
June 08, 2021 | News
iTEAR®100 is an FDA-cleared external neurostimulation device that increases acute tear production. Arctic Vision, a clinical stage biotech company foc...
June 07, 2021 | News
– Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health...
June 03, 2021 | News
TLC (Nasdaq: TLC, TWO: 4152), a clinical‐stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, and...
June 02, 2021 | News
Integrated Prescription Management (IPM), a leading pharmacy benefits management (PBM) company, now offers pharmacogenomics testing for patients...
May 29, 2021 | News
In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...
May 25, 2021 | Analysis
One of the major challenges we currently face is sparse drug discovery pipelines and low clinical trial success rates due to the variability of dru...
May 12, 2021 | Analysis
Apart from possibly Antarctica, there is almost no corner of the globe that will remain entirely unaffected by the COVID-19 pandemic, in terms of healthcar...
May 12, 2021 | Analysis
Most Read
Bio Jobs
News
Editor Picks